cipralisant
Sign in to saveAlso known as (1S,2S)-4-(2-(5,5-dimethylhex-1-inyl)-cyclopropyl)imidazol, gt-2342, GT-2342, (+)-cipralisant
Cipralisant (GT-2331, tentative trade name Perceptin) is an extremely potent histamine H3 receptor ligand originally developed by Gliatech. Cipralisant was initially classified as a selective H3 antagonist, but newer research (2005) suggests also agonist properties, i.e., functional selectivity.
In the Vinony graph
Within Vinony's link graph, cipralisant is referenced by 331 other articles, and connects out to digital object identifier, chemical formula and molar mass.
It is catalogued under topics including Chemical pages without DrugBank identifier, Cyclopropanes and Drugboxes which contain changes to verified fields.
Its subject is documented across 4 Wikipedia language editions.
Wikidata facts
- Mass
- 216.163
Show 4 more facts
- canonical SMILES
- CC(C)(C)CCC#CC1CC1C2=CN=CN2
- chemical formula
- C₁₄H₂₀N₂
- isomeric SMILES
- CC(C)(C)CCC#C[C@H]1C[C@@H]1C2=CN=CN2
- Commons category
- Cipralisant
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Cipralisant (GT-2331, tentative trade name Perceptin) is an extremely potent histamine H3 receptor ligand originally developed by Gliatech. Cipralisant was initially classified as a selective H3 antagonist, but newer research (2005) suggests also agonist properties, i.e., functional selectivity.
The relatively recent cloning of human H3 receptor, as well as the discovery of its constitutive activity provided the ability to better assess the activity of H3 receptor ligands. Consequently, cipralisant was reassessed as an H3 receptor agonist in human and rat recombinant systems, showing functional selectivity and stimulating one type of G-protein coupled pathway while failing to activate other intracellular pathways.
Excerpted from Wikipedia’s “cipralisant” article, available under the CC BY-SA 4.0 licence.